Offer - Urjas Oil for just ₹ 1 X
Forglyn Plus Respicap is an allopathic medicine The correct dosage of Forglyn Plus Respicap depends on the patient's age, gender, and medical history. This information has been provided in detail in the dosage section.
Forglyn Plus Respicap is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Is the use of Forglyn Plus Respicap safe for pregnant women?
Side effects of Forglyn Plus Respicap during pregnancy are not known because scientific research on this topic hasn't been done.
Is the use of Forglyn Plus Respicap safe during breastfeeding?
There is no research available on the side effects of Forglyn Plus Respicap in breastfeeding women. Therefore, its impact is unknown.
What is the effect of Forglyn Plus Respicap on the Kidneys?
There may be some adverse effects on kidney after taking Forglyn Plus Respicap. If you observe any such side effects, stop taking this drug. Consume this medicine again only if your doctor advises you to do so.
What is the effect of Forglyn Plus Respicap on the Liver?
Very few cases of side effects of Forglyn Plus Respicap on the liver have been reported.
What is the effect of Forglyn Plus Respicap on the Heart?
You may experience side effects on your heart after taking Forglyn Plus Respicap. If this happens, then discontinue its use. Consult your medical practitioner, and do as he/she suggests.
Forglyn Plus Respicap should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Forglyn Plus Respicap unless your doctor advises you to do so -
Is this Forglyn Plus Respicap habit forming or addictive?
Forming a habit of Forglyn Plus Respicap has not been reported.
Interaction between Food and Forglyn Plus Respicap
Taking Forglyn Plus Respicap with some specific foods may delay its effect. Talk to your doctor about this.
Interaction between Alcohol and Forglyn Plus Respicap
Due to lack of research, there is no information about the side effects of taking Forglyn Plus Respicap with alcohol.
Yes, Forglyn Plus Respicap help in providing relief from cough, chest tightness and wheezing in asthma and COPD (chronic obstructive pulmonary disease) which is caused by narrowing of the airway s.
No, Forglyn Plus Respicap does not cause gastritis. It has not been reported by the patients who are taking this drug. In fact, oral budesonide is used in the treatment of collagenous gastritis (CG) when other treatment options do not work.
The dosage and duration of using this drug may vary depending upon the age and medical condition of the patient and type of dosage forms. Hence you are advised to take Forglyn Plus Respicap as directed by your doctor. However, the inhaler is used twice daily or advice by the doctor.
Forglyn Plus Respicap is a brand name of budenoside and it is available in the form of an inhaler, respule, nasal spray, and rotacap. It belongs to the class of drugs known as steroids (corticosteroid). It is a prescription drug which is used to prevent asthmatic attacks as maintenance treatment in asthma.
Yes, you can take Forglyn Plus Respicap after albuterol (salbutamol). No harmful drug interaction has been reported between them. However, if you feel any discomfort after taking this drug do not hesitate to inform your doctor.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 356-366
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 231
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Entocort® Ec (budesonide)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Pulmicort Respules™ (budesonide)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Perforomist® (formoterol fumarate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 224
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 595-596
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Robinul Injection (Glycopyrrolate Injection)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 117
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 619-620